| Choctaw General Hospital | |
| 401 Vanity Fair Lane, Po Box 618, Butler, Alabama 36904 | |
| (205) 459-9100 | |
| Not Available |
| Name | Choctaw General Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | 401 Vanity Fair Lane, Po Box 618, Butler, Alabama |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 011304 |
| NPI Number | 1184993727 |
| Organization Name | RUSH HOSPITAL/BUTLER, INC |
| Doing Business As | OCHSNER CHOCTAW GENERAL |
| Address | 401 Vanity Fair Lane, Butler, AL 36904 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 205-459-9100 |
News Archive
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
An innovative study published in Psychotherapy and Psychosomatics has explored the genetic relationship between childhood trauma and emotional inhibition (alexithymia). Existing evidence suggests that both genetic and environmental factors contribute to the development of alexithymia.
Cyrenaic Pharmaceuticals Inc. a private drug development company focused on the treatment of CNS disorders, today announced Phase IIa clinical results for CYR-101, its novel investigational drug for the treatment of schizophrenia. The results from the study showed that the drug alleviated the symptoms of the disease, including the negative and cognitive symptoms.
AVAX Technologies, Inc., a pioneer in personalized cancer vaccines, today announced the results of its Phase 1/2 OVAX study in patients with platinum resistant relapsed Stage III or IV Ovarian Cancer.
The topic of hygiene has come to the forefront in mainstream media as reopening plans are introduced around the globe.
› Verified 8 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
An innovative study published in Psychotherapy and Psychosomatics has explored the genetic relationship between childhood trauma and emotional inhibition (alexithymia). Existing evidence suggests that both genetic and environmental factors contribute to the development of alexithymia.
Cyrenaic Pharmaceuticals Inc. a private drug development company focused on the treatment of CNS disorders, today announced Phase IIa clinical results for CYR-101, its novel investigational drug for the treatment of schizophrenia. The results from the study showed that the drug alleviated the symptoms of the disease, including the negative and cognitive symptoms.
AVAX Technologies, Inc., a pioneer in personalized cancer vaccines, today announced the results of its Phase 1/2 OVAX study in patients with platinum resistant relapsed Stage III or IV Ovarian Cancer.
The topic of hygiene has come to the forefront in mainstream media as reopening plans are introduced around the globe.
› Verified 8 days ago
Choctaw General Hospital Critical Access Hospital Location: 401 Vanity Fair Lane, Po Box 618, Butler, Alabama 36904 Phone: (205) 459-9100 |